Literature DB >> 12439290

The blood-brain barrier creatine transporter is a major pathway for supplying creatine to the brain.

Sumio Ohtsuki1, Masanori Tachikawa, Hitomi Takanaga, Hidemi Shimizu, Masahiko Watanabe, Ken-Ichi Hosoya, Tetsuya Terasaki.   

Abstract

Although creatine plays a pivotal role in the storage of phosphate-bound energy in the brain, the source of cerebral creatine is still unclear. The authors examined the contribution made by the creatine transporter (CRT) at the blood-brain barrier in supplying creatine to the brain from blood. An intravenous administration study suggested that creatine is continuously transported from the blood to the brain against the creatine concentration gradient that exists between brain and blood. Conditionally immortalized mouse brain capillary endothelial cells (TM-BBB) exhibited creatine uptake, which is Na+ and Cl- dependent and inhibited by CRT inhibitors, such as beta-guanidinopropionate and guanidinoacetate. Northern blot and immunoblot analyses demonstrated that CRT is expressed in TM-BBB cells and isolated mouse brain microvessels. Moreover, high expression of CRT was observed in the mouse brain capillaries by confocal immunofluorescent microscopy. These results suggest that CRT plays an important role in supplying creatine to the brain via the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12439290     DOI: 10.1097/01.WCB.0000033966.83623.7D

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  39 in total

1.  Risk for metabolic syndrome predisposes to alterations in the thalamic metabolism.

Authors:  Outi Heikkilä; Nina Lundbom; Marjut Timonen; Per-Henrik Groop; Sami Heikkinen; Sari Mäkimattila
Journal:  Metab Brain Dis       Date:  2008-07-22       Impact factor: 3.584

Review 2.  Solute Carriers in the Blood-Brain Barier: Safety in Abundance.

Authors:  Katarzyna A Nałęcz
Journal:  Neurochem Res       Date:  2016-08-09       Impact factor: 3.996

3.  Cell-Type-Specific Spatiotemporal Expression of Creatine Biosynthetic Enzyme S-adenosylmethionine:guanidinoacetate N-methyltransferase in Developing Mouse Brain.

Authors:  Masanori Tachikawa; Masahiko Watanabe; Masahiro Fukaya; Kazuhisa Sakai; Tetsuya Terasaki; Ken-Ichi Hosoya
Journal:  Neurochem Res       Date:  2017-12-05       Impact factor: 3.996

Review 4.  The molecular and biophysical characterization of the human blood-nerve barrier: current concepts.

Authors:  Eroboghene E Ubogu
Journal:  J Vasc Res       Date:  2013-07-06       Impact factor: 1.934

Review 5.  X-linked creatine transporter deficiency: clinical aspects and pathophysiology.

Authors:  Jiddeke M van de Kamp; Grazia M Mancini; Gajja S Salomons
Journal:  J Inherit Metab Dis       Date:  2014-05-01       Impact factor: 4.982

Review 6.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

7.  Effects of creatine and β-guanidinopropionic acid and alterations in creatine transporter and creatine kinases expression in acute seizure and chronic epilepsy models.

Authors:  Dae Won Kim; Seong-Il Yeo; Hea Jin Ryu; Ji-Eun Kim; Hong-Ki Song; Oh-Shin Kwon; Soo Young Choi; Tae-Cheon Kang
Journal:  BMC Neurosci       Date:  2010-10-28       Impact factor: 3.288

8.  Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic mice.

Authors:  Alpaslan Dedeoglu; James K Kubilus; Lichuan Yang; Kimberly L Ferrante; Steven M Hersch; M Flint Beal; Robert J Ferrante
Journal:  J Neurochem       Date:  2003-06       Impact factor: 5.372

9.  Mechanisms of the penetration of blood-borne substances into the brain.

Authors:  Masaki Ueno
Journal:  Curr Neuropharmacol       Date:  2009-06       Impact factor: 7.363

10.  Developmental changes in the expression of creatine synthesizing enzymes and creatine transporter in a precocial rodent, the spiny mouse.

Authors:  Zoe Ireland; Aaron P Russell; Theo Wallimann; David W Walker; Rod Snow
Journal:  BMC Dev Biol       Date:  2009-07-01       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.